Details for Patent: 6,242,442
✉ Email this page to a colleague
Title: | Brinzolamide and brimonidine for treating ocular conditions |
Abstract: | Methods and compositions for treating ocular conditions which find their etiology in compromised ocular blood flow with brinzolamide and brimonidine are disclosed. |
Inventor(s): | Dean; Thomas R. (Weatherford, TX), Desantis, Jr.; Louis (Fort Worth, TX), York; Billie M. (Conroe, TX) |
Assignee: | Alcon Laboratories, Inc. (Fort Worth, TX) |
Filing Date: | Aug 04, 2000 |
Application Number: | 09/601,634 |
Claims: | 1. A method for treating ocular conditions selected from the group consisting of occlusion conditions, diabetic retinopathy, and neovascularization which comprises administering a pharmaceutically effective amount of brinzolamide and brimonidine. 2. The method of claim 1 wherein the brinzolamide and brimonidine are dosed separately. 3. The method of claim 1 wherein the brinzolamide and the brimonidine are dosed simultaneously in a single formulation. 4. A composition for treating ocular conditions selected from the group consisting of occlusion conditions, diabetic retinopathy, and neovascularization comprising pharmaceutically effective amounts of brinzolamide and brimonidine. |